Etomidate

FDA Approved: * November 4, 1996
Pharm Company: * BEDFORD
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Etomidate Overview

Etomidate[1] (USAN, INN, BAN) (marketed as Amidate) is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation[2] for short procedures such as reduction of dislocated joints, tracheal intubation, and cardioversion. It was developed at Janssen Pharmaceutica in 1964 and was introduced as an intravenous agent in 1972 in Europe and in 1983 in the United States.[3] Contents 1 Medical uses 1.1 Sedat...

Read more Etomidate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Etomidate

Recent Etomidate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Etomidate
  • Injection: 2mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Etomidate: (28 results)

Showing the first 20, Sorted by National Drug Code
  • 0069-0006 Etomidate 2 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0143-9310 Etomidate 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9311 Etomidate 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9506 Etomidate 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9507 Etomidate 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0517-0780 Etomidate 2 mg/ml Intravenous Injection, Solution by American Regent, Inc.
  • 0517-0781 Etomidate 2 mg/ml Intravenous Injection, Solution by American Regent, Inc.
  • 23155-160 Etomidate 2 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
  • 23155-522 Etomidate 2 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
  • 25021-674 Etomidate 2 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 40042-025 Etomidate 2 mg/ml Intravenous Injection, Solution by Pharmaforce, Inc.
  • 42023-169 Etomidate 2 mg/ml Intravenous Injection, Solution by Par Pharmaceutical, Inc.
  • 42023-170 Etomidate 2 mg/ml Intravenous Injection, Solution by Par Pharmaceutical, Inc.
  • 55150-221 Etomidate 20 mg/10ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 55150-222 Etomidate 40 mg/20ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 55390-762 Etomidate 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-763 Etomidate 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 65841-818 Etomidate 2 mg/ml Intravenous Injection, Solution by Cadila Healthcare Limited
  • 67457-183 Etomidate 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-456 Etomidate 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 8 more results ...

Other drugs which contain Etomidate or a similar ingredient: (1 result)

Related Etomidate Topics:

etomidate
sedative...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA